{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:45:41Z","timestamp":1789368341174,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.virol.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T20:46:00Z","timestamp":1458593160000},"page":"213-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals"],"prefix":"10.1016","volume":"492","author":[{"given":"R. Bridget","family":"Ferns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Tarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Urbanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Patrick","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Nastouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Garson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deenan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1099\/0022-1317-73-10-2725","article-title":"Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan","volume":"73","author":"Abe","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2015.06.034","article-title":"Natural history and treatment of HCV\/HIV coinfection: is it time to change paradigms?","volume":"63","author":"Arends","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1073\/pnas.2335981100","article-title":"In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes","volume":"100","author":"Bartosch","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies","volume":"79","author":"Bartosch","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"e16551","DOI":"10.1371\/journal.pone.0016551","article-title":"Within-host dynamics of the hepatitis C virus quasispecies population in HIV-1\/HCV coinfected patients","volume":"6","author":"Bernini","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.virol.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20110868","article-title":"Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2","volume":"443","author":"Boo","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.virol.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1099\/vir.0.80957-0","article-title":"Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection","volume":"86","author":"Brown","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"11956","DOI":"10.1128\/JVI.01079-12","article-title":"Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host","volume":"86","author":"Brown","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"e1002243","DOI":"10.1371\/journal.ppat.1002243","article-title":"Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection","volume":"7","author":"Bull","year":"2011","journal-title":"Plos Pathog."},{"key":"10.1016\/j.virol.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-80-3-717","article-title":"Variation of hepatitis C virus following serial transmission: multiple mechanisms of diversification of the hypervariable region and evidence for convergent genome evolution","volume":"80","author":"Casino","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrgastro.2014.17","article-title":"HCV and HIV co-infection: mechanisms and management","volume":"11","author":"Chen","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virol.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"13609","DOI":"10.1128\/JVI.02119-13","article-title":"Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host","volume":"87","author":"D\u05f3Arienzo","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.diagmicrobio.2008.04.001","article-title":"Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples","volume":"61","author":"Daniel","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virol.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1073\/pnas.1305306110","article-title":"Structural evidence for a bifurcated mode of action in the antibody-mediated neutralization of hepatitis C virus","volume":"110","author":"Deng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"e62684","DOI":"10.1371\/journal.pone.0062684","article-title":"Induction of broadly neutralising HCV antibodies in mice by integration-deficient lentiviral vector-based pseudotyped particles","volume":"8","author":"Deng","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.virol.2016.02.003_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.26733","article-title":"Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry","volume":"59","author":"Douam","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/593067","article-title":"Maternal neutralizing antibody and transmission of hepatitis C virus to infants","volume":"198","author":"Dowd","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with Hepatitis C Virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1128\/JVI.00029-06","article-title":"A conserved Gly(436)-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry","volume":"80","author":"Drummer","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nature05654","article-title":"Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry","volume":"446","author":"Evans","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.virol.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbrc.2006.06.039","article-title":"Efficient amplification and cloning of near full-length hepatitis C virus genome from clinical samples","volume":"346","author":"Fan","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.288.5464.339","article-title":"The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies","volume":"288","author":"Farci","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.virol.2016.02.003_bib27","first-page":"434","article-title":"Assessing HCV acquisition routes in HIV-infected MSM using single genome sequencing-a pilot study","volume":"D674","author":"Fierer","year":"2014","journal-title":"CROI Abstr."},{"key":"10.1016\/j.virol.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/590430","article-title":"Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study","volume":"198","author":"Fierer","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1128\/JVI.78.13.6875-6882.2004","article-title":"Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins","volume":"78","author":"Flint","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2807\/esm.10.05.00535-en","article-title":"Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001\u20132004","volume":"10","author":"Gambotti","year":"2005","journal-title":"Euro Surveill."},{"key":"10.1016\/j.virol.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001432-200502000-00008","article-title":"Management of sexually transmitted infections in HIV positive individuals","volume":"18","author":"Gilleece","year":"2005","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.virol.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/1471-2105-11-532","article-title":"Estimating time since infection in early homogeneous HIV-1 samples using a Poisson model","volume":"11","author":"Giorgi","year":"2010","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.virol.2016.02.003_bib33","doi-asserted-by":"crossref","first-page":"e1002656","DOI":"10.1371\/journal.ppat.1002656","article-title":"A new evolutionary model for Hepatitis C virus chronic infection","volume":"8","author":"Gray","year":"2012","journal-title":"Plos Pathog."},{"key":"10.1016\/j.virol.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jmv.10578","article-title":"The effect of highly active antiretroviral therapy for HIV on the anti-HCV specific humoral immune response","volume":"72","author":"Herrero-Mart\u00ednez","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.meegid.2013.10.021","article-title":"Phylogeny and molecular evolution of the hepatitis C virus","volume":"21","author":"Jackowiak","year":"2014","journal-title":"Infect. Gen. Evol."},{"key":"10.1016\/j.virol.2016.02.003_bib36","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/JVI.00248-09","article-title":"Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity","volume":"83","author":"Keck","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib37","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.02.003_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virol.2016.02.003_bib39","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virol.2016.02.003_bib40","doi-asserted-by":"crossref","first-page":"e52651","DOI":"10.1371\/journal.pone.0052651","article-title":"Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins","volume":"7","author":"Koutsoudakis","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.virol.2016.02.003_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/hep.20542","article-title":"Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus","volume":"41","author":"Lavillette","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2016.02.003_bib42","doi-asserted-by":"crossref","first-page":"e1002881","DOI":"10.1371\/journal.ppat.1002880","article-title":"Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing","volume":"8","author":"Li","year":"2012","journal-title":"Plos Pathog."},{"key":"10.1016\/j.virol.2016.02.003_bib43","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virusres.2007.05.016","article-title":"Trends for genetic variation of hepatitis C virus quasispecies in human immunodeficiency virus-1 coinfected patients","volume":"130","author":"Lopez-Labrador","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2016.02.003_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2016.02.003_bib45","doi-asserted-by":"crossref","first-page":"8496","DOI":"10.1128\/JVI.78.16.8496-8505.2004","article-title":"Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner","volume":"78","author":"McKeating","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2016.02.003_bib47","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib48","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.02.003_bib49","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.virol.2016.02.003_bib50","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.virol.2016.02.003_bib51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/infdis\/jir835","article-title":"Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion","volume":"205","author":"Raghuraman","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2016.02.003_bib52","doi-asserted-by":"crossref","first-page":"e1002881","DOI":"10.1371\/journal.ppat.1002881","article-title":"Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate","volume":"8","author":"Ribeiro","year":"2012","journal-title":"Plos Pathog."},{"key":"10.1016\/j.virol.2016.02.003_bib53","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1128\/JVI.00191-09","article-title":"Coinfection with hepatitis C Virus and human immunodeficiency virus: virological, immunological, and clinical outcomes","volume":"83","author":"Rotman","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib54","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1128\/JVI.00586-11","article-title":"Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step","volume":"85","author":"Sabo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib55","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2016.02.003_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.virol.2013.11.001","article-title":"Transmission and evolution of hepatitis C virus in HCV seroconverters in HIV infected subjects","volume":"449","author":"Shen","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.virol.2016.02.003_bib57","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/JVI.78.7.3447-3454.2004","article-title":"High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression","volume":"78","author":"Sheridan","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib58","doi-asserted-by":"crossref","first-page":"e41997","DOI":"10.1371\/journal.pone.0041997","article-title":"Recombination in Hepatitis C Virus: identification of four novel naturally occurring inter-subtype recombinants","volume":"7","author":"Shi","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.virol.2016.02.003_bib59","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/502974","article-title":"HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability","volume":"193","author":"Shuhart","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2016.02.003_bib60","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1128\/jvi.64.12.5840-5850.1990","article-title":"Analysis of sequence diversity in hypervariable regions of the external glycoprotein of Human-Immunodeficiency-Virus Type-1","volume":"64","author":"Simmonds","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-1119(92)90216-C","article-title":"Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase","volume":"122","author":"Steinhauer","year":"1992","journal-title":"Gene"},{"key":"10.1016\/j.virol.2016.02.003_bib62","doi-asserted-by":"crossref","first-page":"e02518","DOI":"10.1128\/mBio.02518-14","article-title":"Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted\/founder genotypes 1, 3, and 4","volume":"6","author":"Stoddard","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.virol.2016.02.003_bib63","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1099\/vir.0.83065-0","article-title":"Determination of the human antibody response to the epitope defined by the hepatitis C virus neutralizing monoclonal antibody AP33","volume":"88","author":"Tarr","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib64","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1128\/JVI.06492-11","article-title":"Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization","volume":"86","author":"Tarr","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib65","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.3390\/v7072809","article-title":"Genetic diversity underlying the envelope glycoproteins of Hepatitis C Virus: structural and functional consequences and the implications for vaccine design","volume":"7","author":"Tarr","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2016.02.003_bib66","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1002\/hep.1840360726","article-title":"Hepatitis C and human immunodeficiency virus infection","volume":"36","author":"Thomas","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2016.02.003_bib67","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","article-title":"Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men","volume":"60","author":"Thomson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.virol.2016.02.003_bib68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","article-title":"Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV","volume":"23","author":"Thomson","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2016.02.003_bib69","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2893.2009.01215.x","article-title":"The prevalence of hepatitis C virus (HCV) infection in HIV-positive individuals in the UK-trends in HCV testing and the impact of HCV on HIV treatment outcomes","volume":"17","author":"Turner","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virol.2016.02.003_bib70","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/ciu695","article-title":"Hepatitis C virus (HCV) antibody dynamics following acute HCV infection and reinfection among HIV-infected men who have sex with men","volume":"59","author":"Vanhommerig","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2016.02.003_bib71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2016.02.003_bib72","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1128\/JVI.02271-09","article-title":"Hepatitis C virus transmission bottlenecks analyzed by deep sequencing","volume":"84","author":"Wang","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2016.02.003_bib73","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.94.16.8738","article-title":"Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee","volume":"94","author":"Yanagi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2016.02.003_bib74","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.78.3.1448-1455.2004","article-title":"CD81 is required for hepatitis C virus glycoprotein-mediated viral infection","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682216000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:37:41Z","timestamp":1758587861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682216000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":74,"alternative-id":["S0042682216000465"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2016.02.003","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}